Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:JUNS

Jupiter Neurosciences (JUNS) Stock Price, News & Analysis

Jupiter Neurosciences logo

About Jupiter Neurosciences Stock (NASDAQ:JUNS)

Advanced Chart

Key Stats

Today's Range
$1.20
$1.31
50-Day Range
N/A
52-Week Range
N/A
Volume
42,822 shs
Average Volume
166,366 shs
Market Capitalization
$42.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Receive JUNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Jupiter Neurosciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

JUNS Stock News Headlines

Retire Comfortably with These New Monthly Income ETFs?
Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns just aren’t enough anymore. But what if you could reach your Freedom Number—the monthly income that makes retirement secure—using far less money than you thought possible? That’s exactly what Kelly G. discovered. She calls it “life-changing,” saying the income just keeps growing and that early retirement suddenly looks real. This strategy was once reserved for the ultra-wealthy, but it’s now available to everyday investors.tc pixel
See More Headlines

JUNS Stock Analysis - Frequently Asked Questions

Jupiter Neurosciences, Inc. (NASDAQ:JUNS) posted its quarterly earnings results on Monday, August, 18th. The company reported ($0.07) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.07).

Jupiter Neurosciences (JUNS) raised $11 million in an initial public offering (IPO) on Tuesday, December 3rd 2024. The company issued 2,800,000 shares at $4.00 per share. Dominari Securities and Revere Securities acted as the underwriters for the IPO.

Company Calendar

Last Earnings
8/18/2025
Today
9/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
N/A
Current Symbol
NASDAQ:JUNS
CIK
1679628
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.44 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-835.24%
Return on Assets
-155.10%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.07
Quick Ratio
1.07

Sales & Book Value

Annual Sales
$230 thousand
Price / Sales
186.26
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.13 per share
Price / Book
9.46

Miscellaneous

Outstanding Shares
34,830,000
Free Float
N/A
Market Cap
$42.84 million
Optionable
Not Optionable
Beta
N/A
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:JUNS) was last updated on 9/7/2025 by MarketBeat.com Staff
From Our Partners